Clinical trials
Phase 3 Lung Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| United Therapeutics | 2 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Pfizer | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Shanghai Gebaide Biotechnology Co., Ltd. | 1 |
| Shanghai Pulmonary Hospital, Shanghai, China | 1 |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 13 |
| Respiratory Tract Diseases | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Lung Neoplasms | 5 |
| Carcinoma, Bronchogenic | 4 |
| Thoracic Neoplasms | 4 |
| Bronchial Neoplasms | 3 |
| Connective Tissue Diseases | 3 |
| COVID-19 | 2 |
| Cardiovascular Diseases | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.